AACR Annual Meeting 2018: Novel Immunotherapy Combinations to Combat Resistance to Checkpoint Inhibition

An exciting area in drug development, immunotherapy is being increasingly utilized by patients with different cancer types. These treatments work by stimulating the patient’s immune system to effectively target and …

Read More

Advice from Advocates: How to Navigate the Annual Meeting

Two graduates of the AACR Scientist↔Survivor Program, a special educational experience that gives patient advocates the opportunity to attend and learn from researchers at the AACR Annual Meeting, have put together some tips to help guide advocates who are attending this or any large scientific conference.

Read More

Improving the Effectiveness of CAR T-cell Immunotherapy

A study presented in the AACR Annual Meeting 2018 Media Preview webinar, held March 15, examined closely a key ingredient necessary to make effective chimeric antigen receptor (CAR) T cells – the T cells of a patient. The researchers behind this study have identified one potential reason for why we have not been successful in making CAR T-cell therapy work against solid tumors, and offer a solution.

Read More

AACR Previews Research from Annual Meeting 2018

In less than a month, the AACR Annual Meeting 2018 will kick off in Chicago, Illinois. The meeting is expected to draw about 22,000 attendees, including cancer researchers, clinicians, and advocates.

As always, the meeting features a wide range of high-impact science, featuring presentations on all aspects of basic and translational cancer research, including immunotherapy, precision medicine, artificial intelligence, liquid biopsy, early detection, cancer interception, prevention, cancer disparities, and survivorship.

Read More